April 19, 2026 19:45 ET | Source: Sutro Biopharma, Inc. STRO-004 demonstrates robust and consistent antitumor activity across multiple TF-expressing…
Akron, OH, April 18, 2026 (GLOBE NEWSWIRE) -- This article contains affiliate links. If a purchase is made through these…
Largo, FL, April 18, 2026 (GLOBE NEWSWIRE) -- This release provides an informational summary of Vigor Boost Gummies based on…
Largo, FL, April 18, 2026 (GLOBE NEWSWIRE) -- This report contains affiliate links. If a purchase is made through these…
ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head, double-blind, randomized phase 4 study…
Aurora, CO, April 18, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This release is for informational purposes only and does not constitute…
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease…
PASADENA, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions for nearly…
Company Announcement COPENHAGEN, Denmark; April 17, 2026 – Genmab A/S (Nasdaq: GMAB) At Genmab A/S’ Annual General Meeting on March…
MESQUITE, NV, April 17, 2026 (GLOBE NEWSWIRE) -- Dogecoin Cash, Inc. (OTCQB: DOGP) (“DOGP” or the “Company”) today announced it…